Cabaletta Bio Announces Commercial Agreement With Cellares To Supply Rese-Cel Using Cellares' Automated Cell Shuttle To Enable Flexible Low-Cost Commercial Scaling

Benzinga Newsdesk www.benzinga.com Positive 82.3%

Neg 0% Neu 0% Pos 82.3%

Comments

No comments yet. Be the first!